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Abstract 
Robert Krafty, PhD 
 
Statistical Learning for the Analysis of Multimodal Sleep in Older Men 
Jianhui Zhu, MS 
University of Pittsburgh, 2019 
 
 
Abstract 
 
Introduction: Sleep is essential for human development and maintaining physical and 
mental health. Sleep disturbances have long been known to be associated with mental illness, 
metabolic, neurological or other systems diseases. Knowing what factors are associated with sleep 
quality and sleep-wake homeostasis is important for the study of sleep disorders and may 
potentially inform new treatment strategies to preserve patients' normal sleep-wake cycle. The 
present study aims to identify what actigraphic measures, self-reported sleep variables, and other 
chronic diseases, medications are related to the percentage of slow-wave sleep and delta power 
spectra in older men.  
Method: Categorical variables are summarized using frequencies and percentages.  For 
continuous variables, means and standard deviations are computed, and distributions are displayed 
in histograms. Possible correlations among variables are examined by a matrix of scatterplots and 
Pearson correlation coefficients.  The LASSO is used for feature selection in multiple linear 
regression models and multiple imputation used to overcome missing data.  
Results: The past month sleep hours (β=0.0896, p<0.05), kidney diseases (β=0.161, 
p<0.05)  and oral corticosteroids (β=0.148, p<0.05) are significantly positively associated with 
percentage of deep sleep, while sleep apnea severity (β=-0.0043, p<0.001), age ( = -0.0042, 
p<0.01), Benzodiazepine use ( -0.155, p<0.001), NSAIDS use (β=-0.0418, p<0.05), and race(β=-
 v 
0.0476, p<0.01) are negatively associated when controlling other variables’ effect.  Cognitive 
function (β=0.0015, p<0.001), and oral corticosteroids (β=0.0733, p<0.01) are positively related 
to delta power, while sleep apnea severity (β=-0.0011, p<0.001), age ( = -0.0013, p<0.05), mean 
sleep minutes (-0.0002, p<0.001) , BMI (-0.031, p<0.001), Diabetes (β=-0.0404, p<0.001), 
Benzodiazepine use ( -0.061, p<0.001), and the consumption of alcoholic beverages (β=-0.0125, 
p<0.05) are negatively related to delta power when controlling other covariates. 
Conclusions: Our study suggested several factors are either positively or negatively 
associated with the percentage of deep sleep and delta power. Most of the factors affect the 
percentage of slow-wave sleep and delta power in the same direction.   
Public Health Significance: These analyses may provide important messages for future 
study and potential medical interventions application. 
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1.0 Introduction 
Sleep plays an important role in maintaining the body’s circadian rhythm, physical and 
mental health 1-4. Sleep cycles consist of non-rapid eye movement (NREM) sleep, which is 
subdivided into the three stages N1, N2, and N3, and rapid eye movement sleep (REM). 
Polysomnography (PSG), or the comprehensive recording of electrophysiological changes that 
occur during sleep, is used by clinicians and researchers for evaluating sleep.  Included are 
electroencephalography (EEG), which records brain activity, and is used to define sleep-wake 
cycles, sleep stages, and sleep waves. Figure 15 displays typical EEG signals during different sleep 
stages.  In particular, N3 stage sleep is characterized by low-frequency waves in the 0.5–4.5 Hz 
range and is often referred to as delta wave, slow-wave sleep (SWS), or deep sleep. This stage is 
important for health and functioning as it is during N3 sleep when body restoration, growth, and 
development occurs, immune function is boosted, and energy builds up 6. A comprehensive sleep 
profile includes sleep duration and sleep quality 7. Sleep duration is simply defined by the amount 
of sleep during the night. The normal sleep time is age dependent. Based on the National Sleep 
Foundation’s recommendations 8, the normal sleep duration range for older adults (> 65 yr.) is 7-
8 hours. Short sleepers are generally defined as those who sleep less than 7 hours/night. Sleep 
quality can be defined in different ways. One of the common assessments for sleep quality and 
disturbance is the Pittsburgh Sleep Quality Index (PSQI), a self-rated questionnaire 9. This 
assessment is simple, easy, and cost-effective, but it is subjective and may not be correlated with 
objective measures of sleep 10. Objective measures of sleep by PSG can characterize sleep quality 
by the total sleep time (TST), time spent awake after sleep onset (WASO), sleep efficiency (the 
ratio of TST to time in bed), and the amount of  
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Figure 1 Representative EEG recording during sleep 
 
Slow-wave sleep (SWS, stage 3) and rapid eye movement (REM) sleep 11. Since SWS 
sleep plays important roles in cerebral restoration, the maintenance of sleep, and memory 
consolidation in humans, 12, the percentage of total sleep time that is in stage 3 and 4 is a critical 
measure of deep sleep.  Another useful measure computed from the EEG channel of PSG is the 
amount of delta power during the night.  Delta power is correlated with the change of sleep duration 
and intensity, which are considered as a critical measure for deep sleep 13.  It is also related to prior 
sleep quality and wakefulness and acted as an index for sleep-wake homeostasis. Sleep deprivation 
will evoke an increase of delta power, while excess sleep leads to decrease of delta power 13. Low 
levels of delta power are related to reduced sleep quality in aging patients and patients with 
diseases such as diabetes 1. Delta wave analysis is used to study the homeostatic process in the 
two-process model of sleep regulation 14.  
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Disturbance of sleep such as abnormal sleep duration and poor sleep quality is correlated 
with cardiovascular diseases, metabolic abnormalities, neuronal function, diabetes, depression, 
falls, accidents, impaired cognition, a poor quality of life, and even mortality risk for some diseases 
1 7 15-18. On the other hand, many diseases such as cancer, neurodegenerative diseases including 
Parkinson’s and Alzheimer’s, medications, cardiovascular diseases, metabolic diseases, diet, 
cocaine, or even lifestyle changes and environmental changes could compromise sleep patterns 
and sleep quality 1 19-25. 
Knowing participants’ slow-wave sleep could provide important information related to the 
patient’s general health status, physical or mental stress, and even disease progress. Sleep 
parameters from PSG are considered definitive, “gold standard” measures 26.  However, PSG is 
expensive and requires professionals to perform. Actigraphy is one type of wearable technology 
that uses accelerometer-based transformations to quantify physical activity 27. They are 
noninvasive, objective (provides an accurate representation of sleep/wake history), continuous 
monitoring (for day and night, weeks/months), low cost, and very convenient. If actigraphic sleep-
wake activities and other covariates including self-reported sleep information, medication, and 
chronic disease history can be used to estimate patients’ sleep quality, it could not only serve as a 
screening test for sleep disturbance, but also be used as a monitoring system to evaluate the 
effectiveness of medical or psychological intervention for some diseases 28.    
In this study, we will use statistical learning to analyze multimodal sleep in older men. We 
aim to identify which actigraphy, self-report, clinical and demographic factors are related to slow-
wave sleep and delta power spectra. The results from this study could provide important 
information for the future sleep study and for potential physical/pharmacological intervention to 
preserve SWS/delta power in aging.   
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2.0 Materials and Methods 
2.1 Participants 
Data are from an NIH-funded study in the Osteoporotic Fractures in Men (MrOS) 
conducted between December 2003 and March 2005 at six clinical centers in the United States 
(Birmingham, Alabama; Minneapolis, Minnesota; Palo Alto, California; Monongahela Valley, 
Pennsylvania; Portland, Oregon; and San Diego, California). 5994 community-dwelling men aged 
65 or older were enrolled at 6 clinical centers in a baseline examination between 2000 and 2002. 
After excluding participants who had used overnight nocturnal oxygen therapy or positive 
pressure/oral appliances for the treatment of sleep apnea or other sleep problems, 3135 participants 
were recruited to the Sleep Study. These participants underwent full unattended PSG and 3 to 5-
day actigraphy studies between December 2003 and March 2005. However, our original dataset 
included 5994 observations and 44 variables. 
2.2 Measures 
2.2.1  Outcome Measures 
There are two outcome variables that objectively measure “deep sleep”. The first one is the 
percentage of total sleep time spent in stage 3 and stage 4 sleep, which was calculated as the 
participants’ slow-wave sleep time in NREM, N3, divided by total sleep time per night. The 
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secondary outcome variable is delta power, which was computed from the EEG delta wave signal 
by fast Fourier transform with Welch’s method after artifact removal with automated pipeline 29. 
The average absolute delta spectral power density in log10(uV^2/Hz) was calculated for each sleep 
cycle within the delta band of frequencies between 1.25-4 Hz. 
2.2.2  Rest-activity Circadian Rhythm (RAR) Variables 
 The RAR is measured by actigraphy, which are wearable devices to record acceleration 
and provide indirect measures of physical activity over time. Participants were trained to use the 
Actiwatch 2 device. Their daily regular sleep-wake hours and rest-activity were recorded. To avoid 
masking of the rest-activity cycle, they are advised to avoid alcohol and caffeine during the data 
collection week. Sleep and activity levels were primarily calculated using the Respironics 
Actiware 5.70.1 software (Philips Respironics®, Andover, MA, USA), and recordings per minute 
for six complete days and seven nights were used for the analysis 27.  
A common parametric approach to analyzing RARs includes fitting a 5-parameter extended 
cosine model 30. A new approach referred to as the residual circadian spectrum (RCS) has been 
reported recently 31. The RAR measures included in this study are 1. Mean minutes – sleep in bed; 
2. Mean sleep efficiency – calculated as the percentage of sleep time divided by time in bed; 3. 
Amplitude – peak-nadir difference; 4. MESOR – middle of modeled rhythm; 5. Phi – the time of 
day of the average peak activity over the week with later peak times indicating later timing of high 
activity levels. 6. Pseudo F – the extended cosine model also provided for a measure of how well 
the observed activity data are fitted by the 24-hour rhythm model.  For the pseudo F, lower values 
indicate poorer model fit, which suggests that the rhythm may be erratic, and/or variable 27. Some 
of these measures are illustrated in Figure 2 cited from the published paper 25. 
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Figure 2 Illustration of 5 parameter extended cosine model 
2.2.3  Self-reported Sleep Variables 
 Self-reported sleep variables include participants’ last month’s daily sleep hours (during 
the past month, how many hours of actual sleep did you get each night?) and sleep efficiency (sleep 
time divided by total time in bed). 
2.2.4  Chronic Diseases, Medications, and Other Covariates 
The covariates we considered in this study include demographic/lifestyle factors (age, race, 
education, weekly alcohol consumption, smoking status, body mass index (BMI), self-reported 
physical activity, mental health characteristics (Teng 3MS score, range from 0 to 100 ), depression 
(geriatric depression score, GDS, >5 suggesting, ≥10 depression), anxiety symptoms (Goldberg 
Anxiety Scale score, ranges from 0 to 9, the higher the score, the more likely anxiety), chronic 
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diseases (Peripheral vascular disease, Osteoarthritis, Rheumatoid Arthritis, Hypertension, Stroke, 
Angina, Congestive Heart Failure, Myocardial Infarction, Diabetes, COPD, Parkinson's, Renal 
disease, Cataracts, Liver disease), current medication use (antidepressant such as non-
benzodiazepine non-barbiturate sedatives /hypnotics and  benzodiazepines use), nonsteroidal anti-
inflammatory drugs (NSAID) use, and corticosteroid use (oral or nasal/inhaled).  The severity of 
sleep-disordered breathing was assessed with obstructive apnea-hypopnea index, defined as the 
number of respiratory events with oxygen desaturation ≥ 3% per hour. 
2.3 Missing Data 
 The overall data inspection was analyzed by the Amelia II program 32. Participants who 
have missing data for most of the measures will be excluded from the dataset. After that, all 
remaining missing data were multiply imputed via the Amelia II program which use Expectation-
Maximization Bootstrap-based algorithm (EMB) with consumption of multivariate normal 
distribution.  Five imputed datasets will be generated, and all the data sets were used for modeling. 
The mean of the parameters was calculated and reported.  
2.4 Statistical Analysis 
The data contains two continuous outcomes variables and over 40 predictors and 
covariates. In exploratory analyses, categorical variables are summarized using frequencies and 
percentages. Continuous variables are computed for their mean and standard deviation; their 
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distributions are displayed in histograms. The possible correlation between continuous variables 
is examined by a matrix of scatterplots. Pearson correlation coefficients are calculated.  A multiple 
linear regression model will be fitted as follows: 
𝑦𝑦𝑖𝑖= 𝛽𝛽0+∑ 𝛽𝛽𝑗𝑗𝑝𝑝𝑗𝑗=1 𝑥𝑥𝑖𝑖𝑗𝑗+ 𝜀𝜀𝑖𝑖 
For 𝑖𝑖 ∈  {1 − 𝑛𝑛}, where 
𝑦𝑦𝑖𝑖 is the real-valued response for the i-th observation 
  β0 is the regression intercept 
βj is the j-th predictor’s regression slope 
xij is the j-th predictor for the i-th observation 
𝜀𝜀𝑖𝑖 iid N (0, 𝜎𝜎2) is a Gaussian error term 
  
The regression model is fit using the LASSO, which is a method for shrinkage and selection 
for regression and generalized regression problems 33 to perform multiple variables regression. 
LASSO was computed using glmnet package for R statistical software, version 1.1.14 as per the 
following equation: 
 
where 
N is the number of observations 
yi is the response at observation i 
xi is data, a vector of p values at observation i 
λ is a nonnegative regularization parameter corresponding to one value of Lambda 
The parameters β0 and β are scalar and p-vector, respectively 
 9 
The LASSO problem involves the L1 norm of β. As λ increases, the number of nonzero 
components of β decreases.  The best penalty tuning parameter of the LASSO λ was chosen by the 
program based on 10-fold cross validation that generated the smallest average MSE. The model 
per imputed data set that corresponded to the optimal penalty was referred to as “best”. The 
multiple linear models were run after LASSO performed feature selection with computation of 
inferences. The results from multiple imputations are combined using the Zelig package 34. 
To check the overall goodness of fit, I tested for normality of residuals by plotting the 
observed values against the predicted values, accumulated residuals distribution, and Q-Q 
normality plot.  
2.5 Software 
All analyses were implemented using the RStudio statistical software, version 1.1.141. The 
Amelia II package 32 was used to performing missing data mapping and imputation. Variable 
selection and model fitting was performed using the glmnet 35 and Plotmo package.  Multiple linear 
regression is fitted using ordinary least squares after LASSO feature selection.  The results from 
multiple imputations are combined using the Zelig package34.  
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3.0 Results 
3.1 Data Inspection and Manipulation 
Our raw dataset has 5994 observations and 44 variables. When checking the data using the 
Amelia II package, there is a total of 44% of missing values (Figure 3). Clearly, most of these 
participants who are missing in the outcome variable percentage of slow-wave sleep also have 
missing data in most of the other variables. These observations were excluded from the dataset. 
After removing these observations, there was 1% missing values (Figure 4). In the variable level, 
data was missing in the range of 0 to 14.7% among the predictors and the outcome variable (delta 
power). All remaining missing values were multiply imputed via Amelia II program as showed in 
Figure 5.  A total of 5 datasets were generated for further analysis. For sleep hour data, raw data 
had hour ranges from 0 to 12 hours. According to the National Sleep Foundation’s new 
recommendation 8, I categorized the sleep hours into three groups – less than 5 hours, 5 to 9 hours, 
and more than 9 hours).  
3.2 Descriptive Analysis of Variables 
First, the distribution of the outcome measures, delta power spectra, and the percentage of 
slow-wave sleep were characterized (Figure 6 and Table 1). Delta power is approximately 
normally distributed (Figure 6A), but the percentage of slow-wave sleep distribution was highly 
skewed (Figure 6B). The log transformation (Log (percentage of slow-wave sleep +1)) seemed to 
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improve the distribution pattern (Figure 6C). However, the Shapiro-Wilk test of normality 
suggests the outcome may not be normally distributed (W=0.93, P-value < 0.001). In a very large  
 
 
Figure 3 Missingness Map for raw data 
 
sample size, this should be not a concern for linear regression analysis, but log transformation did 
improve our regression model fitting (see results), therefore we will choose the log-transformed 
percentage of slow-wave sleep for further analysis. 
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Figure 4 Missingness map after excluded missing value in variables for the percentage of 
slow-wave sleep 
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Figure 5 Missingness map after imputation via Amelia II 
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Figure 6 Distribution of delta power and percentage of slow-wave sleep 
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The Modified Mini-Mental State Test (3MS) scores are highly skewed (Figure 7a), The 
mean 3MS Score is 92.6 with a standard deviation of 6.4. Lower 3MS scores indicate cognitive 
impairment 27, so we decided to exclude observations with 3MS scores lower than 80 27 (3.7% of 
the participants were excluded) to avoid possible interference with our analysis (Figure 7b). 
 
 
 
Figure 7 Distribution of Participants’ Mental State Test Score before (A) and after (B) 
excluded those samples with scores lower than 80 
 
 
Table 1 Rest-activity Rhythm and Outcomes Variables 
 
Outcomes variables Mean (SD) 
Delta Power Spectrum (Log level) 1.196 (0.186) 
Percentage of slow-wave sleep (Log level) 0.934 (0.411) 
Rest-Activity rhythm variables  
Mean Minutes Scored as Sleep INBD 385 (72.85) 
Mean SLP EFF (%) INBD 78.34 (11.87) 
Amplitude Antilogistic 3623 (1089) 
PHI Antilogistic 14.26 (1.19) 
Pseudo F Antilogistic 1047 (505.6) 
MESOR Antilogistic 2173 (506.8) 
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The final dataset contains 2767 observations. The mean age is 75.24 years old. 90.67% of 
participants were white; black and other ethnicities amounted to 3.38% and 5.95% of the  
sample, respectively (Table 2). 96.09% of last month’s daily sleep hours fell in the 5 to 9 
hours group, which is considered a normal sleep time for those over 65 years old. 8. Alcohol 
consumption and smoking information are also characterized in Table 2. The mean score of the 
Teng mini-mental state examination after excluding those with scores less than 80 is 93.47 with a 
standard deviation of 4.46. Using this cut-off could prevent possible biased self-reported 
information used in the analysis by some older participants who have some mental diseases. The 
mean value, standard deviation, and histograms of these self-reported variables are summarized in 
Table 2 and Supplemental Figure S1.  
The RAR variables provide objective measures for sleep-wake variables. The mean 
minutes of sleep and mean sleep efficiency are 385 (± 72.85, SD) minutes and 78.34% (± 11.87, 
SD), respectively (Table 1). Phi, an index for the peak of activity, higher values of which may 
indicate a more delayed rhythm 36, has a mean of 14.26 and a standard deviation of 1.19. The 
Pseudo F, provided by the extended cosine model, has a mean of 1057 with a standard deviation 
of 505.6. The higher the value of Pseudo F, the more robust the rhythm and better cosine model 
fitting 27. Amplitude and MESOR have means of 3623 (±1089) and 2173 (±506.8), respectively. 
All RAR measures included in this study are shown in Table 1 and Supplemental Figure 
S2 (histogram). The participants’ chronic diseases and current medication use information are 
summarized in Table 3.  
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Table 2 Sample Characteristics 
 
Age (yr.) 76.24(5.46) 
Body Mass Index 27.19(3.78) 
Education (n, %)  
       < High school 126(5.22) 
       High school 441(16.30) 
       > High school 2200(78.48) 
Race (n, %)  
       White 2532(90.67) 
       Black 79(3.38) 
       Other 156(5.95) 
Alcohol drinks (n, %)  
       ≤1 drink / week 1267(46.02) 
       2-13 drinks/week 1336(48.53) 
       ≥14 drinks / week 150(5.45) 
Smoke (n,%)  
       Never 1101(39.80) 
       Ever 1610(58.21) 
       Current 55(1.99) 
Past month sleep hour (n, %)  
       < 5 106(3.83) 
       5-9 2659(96.09) 
       >9 2(0.07) 
Sleep efficiency 86.23(12.17) 
Physical activity score 146.5(71.04) 
Geriatric depression score 1.71(2.11) 
Goldberg anxiety scale score 0.90(1.90) 
Mental state examination score 93.47(4.46) 
Obstructive apnea-hypopnea index 16.86(14.54) 
Mean (standard deviation) shown unless otherwise noted 
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Table 3 Chronic Diseases and Medication Use 
 
 
Multicollinearity of continuous variables is examined by a matrix of the scatterplot. Figure 
8 displays the correlation between actigraphic variables and outcome variables. Figure 9 displays 
the correlation between outcome variables and other continuous variables. The Pearson correlation 
coefficients were computed (Supplemental Table S1). As expected, there are positive correlations 
between delta power and percentage of slow-wave sleep (ρ =0.63), between mean minutes scored 
as sleep  and mean sleep efficiency (ρ=0.76), between amplitude and MESOR (ρ=0.80), and 
between Pseudo F  and amplitude (ρ=0.55), because some of them were computed by use of the 
same raw/signal parameters, such as amplitude using peak – nadir activity difference, while 
MESOR is mean activity.   
    
Chronic Diseases n NO (%) YES (%) 
       Diabetes 2766 86.98 13.02 
       Osteoarthritis 2765 92.08 8.92 
       Rheumatoid Arthritis 2765 75.73 24.27 
       Parkinson Disease 2766 98.95 1.05 
       Liver Disease 2766 97.87 2.13 
       Kidney Disease / Failure 2766 98.99 1.01 
       COPD / Emphysema 2766 94.87 5.13 
       Cataract 2766 53.62 46.38 
       Heart Attack 2766 82.79 17.21 
       Angina 2766 85.14 15.86 
      Congestive Heart Failure 2766 94.03 5.97 
      Stroke 2766 96.28 3.72 
      Hypertension 2766 50.25 49.75 
      Peripheral Arterial Disease 2723 90.12 9.88 
Medications    
       Antidepressant 2767 92.48 7.52 
       Benzodiazepine 2767 95.59 4.41 
       NSAID 2767 79.40 20.60 
       Nonbenzo Nonbarbituate Sedative Hypnotic 2767 97.98 2.02 
       Oral Corticosteroids 2758 98.19 1.81 
       Inhaled / Nasal Corticosteroids 2762 92.34 7.66 
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Figure 8 Correlation among actigraphic variables and outcome variables 
 
 
Figure 9 Correlation among outcome variables and other continuous variables 
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3.3 LASSO regression for the percentage of slow-wave sleep 
 
The multiple variants regression analysis was performed by using the glmnet package with 
default settings (standardize = True, program decide the range and tuning parameter λ). The best 
value of λ was chosen by 10-fold cross-validation based on minimum mean squared error. Figure 
10 provides an illustration of 10-fold cross-validation applied to the LASSO fits of our dataset. 
The left vertical dashed line indicates a λ that gives the minimum mean cross-validated error, and 
the right vertical dashed line indicates a λ that gives a model such that the error is within one 
standard error of the minimum. 
 
 
Figure 10 Ten-fold cross-validation MSE for the LASSO, applied to the dataset to select the 
lambda for the percentage of slow-wave sleep 
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Figure 11 The corresponding LASSO coefficient estimates for the percentage of slow-wave 
sleep 
 
 
Figure 11 displays the coefficient estimates after variant selection and dimension 
shrinkage applied to the LASSO model. The vertical line indicates the best λ value for this model. 
Each line represents one of the explanatory variables and its role in the model. In the plot, we can 
see when each variable entered the model and to what extent they influenced the response variable. 
Entering the model early and steadily with a large coefficient plays a big role in the model. In this 
model, the benzodiazepine, commonly used for depression and anxiety, is the first variable to enter 
the model. It has a negative effect on deep sleep, while oral corticosteroids, kidney disease, and 
past month sleep hours have a positive effect on predicting the percentage of deep sleep. We use 
the same strategy to repeat all five multiple imputed data. The averaged results are shown in Table 
4. We also ran a multiple linear regression model and its estimation using ordinary least squares 
(OLS) for variables selected by the LASSO process to compute the p-values. The results from 
multiply imputed datasets are combined to reflect the average change using Zelig package 34. The 
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results and comparison between multiple linear regression and LASSO regression are shown in 
Table 4. After controlling for all other covariates, the past month sleep hours are positively 
associated with the percentage of slow-wave sleep  (βLASSO=0.05686, p=0.024), while the 
obstructive apnea-hypopnea index is negatively associated with the percentage of slow-wave 
sleep, conditional on controlling other covariates (βLASSO =-0.0039, p<0.001). Detailed results are 
shown in Table 4. Compared with multiple linear regression, LASSO has much smaller 
coefficients because the nature of L1 penalty shrinks coefficients toward the null.  
 
Table 4 Models for the Percentage of Slow-wave sleep 
 LASSO Multiple linear regression 
Covariates Parameter Parameters SE P value 
Intercept 0.8606 0.968 0.25 0.00015*** 
Coefficients     
Past Month Sleep Hours 0.0569 0.0896 0.039 0.024* 
Obstructive Apnea Hypopnea Id. -0.0039 -0.0043 0.0005 0.0000*** 
Mental State Test Score 0.0028 0.0035 0.0017 0.051 
Age -0.0024 -0.0042 0.0015 0.0057** 
Body Mass Index -0.0004 -0.0026 0.0022 0.234 
Kidney Diseases 0.0583 0.161 0.0766 0.0349* 
Heart Attack -0.011 -0.033 0.0204 0.099 
Benzodiazepine -0.114 -0.155 0.0374 0.0000*** 
NSAID -0.0199 -0.0418 0.019 0.028* 
Oral Corticosteroids 0.0796 0.148 0.057 0.0101** 
Race -0.0266 -0.0476 0.0162 0.0033** 
 
 
 
 23 
3.4 LASSO Regression for Delta Power Spectra 
Similarly, we fitted a LASSO model for delta power spectra. The illustrations of 10-fold 
cross-validation and selection of parameters are displayed in Figure 12 and Figure 13. The tuning 
parameter λ for minimum mean squared error in this model is 0.0031 (Figure 13). The selected 
variables based on the λmin are summarized in Table 5. The computed p-values after multiple linear 
regression are also showed in Table 5. Our results showed that except a few variables such as 
diabetes, benzodiazepine, BMI, obstructive apnea-hypopnea index, the majority of variables has 
very small, non-significant coefficients. Since the dependent variable delta power has 14.7% 
missing; it may potentially add needless noise when running a regression model using imputed 
values for delta 37 and could affect the model fitting. Therefore, we created a second dataset 
(dataset2) by removing missing delta, then performed multiple imputations for other missed 
predictors. The results compared with those using dataset1 are displayed in Table 6. As shown in 
the table, the majority of coefficients between the two models are very close suggesting that even 
dependent variable has about 15% of missing data, the mean coefficients calculated from LASSO 
models using generated multiple imputations still quite reliable. However, the variable selection 
in this model using the λmin is not very powerful. From Figure 13,  many covariates around 0 could 
be just noise, In Figure 12, within the λmin to one standard error of the minimum λ range (between 
two vertical dashed lines), the log (lambda) level increase from -6.1 to about -5.3 does not 
substantially change the mean squared error, but significantly increases the penalty power. We 
remodeled the LASSO linear regressing using λ = exp-5.3 and the result is shown in Table 7. 
Conditional on controlling other variables, age, BMI, mean sleep minutes, diabetes, 
benzodiazepine, nonsteroidal anti-inflammatory drugs, and alcohol drinks are negatively 
associated the delta power, while Parkinson disease and mini-mental state examination score are 
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positively associated with the delta power. The p-values are also displayed in Table 7.  Similarly, 
a combination of regression results from multiply imputed datasets is analyzed using the Zelig. 
Results are displayed in Table 7.  
  
Figure 12 Ten-fold cross-validation MSE for the LASSO, applied to the dataset to predict 
the Delta Power Spectra 
 
 
Figure 13 The corresponding LASSO coefficient estimaes for Delta Power 
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Table 5 Model for Delta Power Spectra using λmin 
Covariates Best Model parameters P Value 
   Intercept 1.31147 0.000** 
   Coefficients   
Past Month Sleep Hours 0.011532 0.099 
Obstructive Apnea Hypopnea Index -0.000938 0.000** 
Mental State Test Score 0.000978 0.212 
Age -0.000814 0.0923 
Body Mass Index -0.002471 0.002** 
Physical Activity -0.000032 0.218 
Mean Minutes Scored as Sleep INBD -0.00014 0.127 
Mean SLP EFF (%) INBD -0.000187 0.158 
Amplitude Antilogistic 0.000003 0.0506 
Diabetes -0.033098 0.000** 
Osteoarthritis -0.002618 0.222 
Parkinson Disease 0.022895 0.2914 
COPD / Emphysema 0.010604 0.161 
Congestive Heart Failure -0.005931 0.306 
Hypertension -0.005282 0.432 
Benzodiazepine -0.047638 0.000** 
NSAID -0.008208 0.211 
Nonbenzo Nonbarbituate Sedative Hypnotic -0.013197 0.430 
Oral Corticosteroids 0.054667 0.0163* 
Inhaled / Nasal Corticosteroids 0.009406 0.145 
Race -0.006050 0.045* 
Education 0.003584 0.209 
Alcohol Drinks -0.008557 0.0105* 
 
 
  
 26 
Table 6 Comparison of Models for Delta Power Spectra Using Two Different Datasets 
Covariates Parameters in 
Dataset1 
Parameters in 
Dataset2 
   Intercept 1.31147 1.2936 
   Coefficients   
Past Month Sleep Hours 0.011532 0.01257 
Obstructive Apnea Hypopnea Index -0.000938 -0.0009246 
Mental State Test Score 0.000978 0.0009483 
Age -0.000814 -0.000906 
Body Mass Index -0.002471 -0.00237 
Physical Activity -0.000032 -0.0000428 
Mean Minutes Scored as Sleep INBD -0.00014 -0.000114 
Mean SLP EFF (%) INBD -0.000187 -0.0000831 
Amplitude Antilogistic 0.000003 0.0000017 
Diabetes -0.033098 -0.03277 
Osteoarthritis -0.002618 -0.00374 
Parkinson Disease 0.022895 0.0225 
COPD / Emphysema 0.010604 0.023028 
Congestive Heart Failure -0.005931  
Hypertension -0.005282 -0.007239 
Benzodiazepine -0.047638 -0.04633 
NSAID -0.008208 -0.00773 
Nonbenzo Nonbarbituate Sedative Hypnotic -0.013197 -0.0211 
Oral Corticosteroids 0.054667 0.04618 
Inhaled / Nasal Corticosteroids 0.009406 0.0127 
Race -0.006050 -0.00526 
Alcohol Drinks -0.008557 -0.0073578 
EDU 0.003584 0.003989 
Dataset1 has missing delta (14.7%) with imputation 
Dataset2 excludes the missing delta, then imputed using Amelia II 
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Table 7 Models for Delta Power Spectra 
 LASSO λbest Multiple linear regression 
Covariates Parameters  Parameters SE P Value 
   Intercept 1.251 1.351 0.113 0.000*** 
   Coefficients   
Obstructive Apnea Hypopnea Id. -0.0008 -0.0011 0.0003 0.000*** 
Mental State Test Score 0.00068 0.0015 0.0008 0.061 
Age -0.0003 -0.0013 0.0007 0.067 
Body Mass Index -0.0017 -0.0031 0.001 0.003** 
Mean Minutes Sleep INBD -0.0001 -0.0002 0.00005 0.000*** 
Diabetes -0.0283 -0.0404 0.0109 0.000*** 
Parkinson Disease 0.00393 0.046 0.0376 0.217 
Benzodiazepine -0.0354 -0.061 0.0183 0.000*** 
Hypertension -0.0038 -0.0087 0.0077 0.255 
NSAID -0.0021 -0.0149 0.0091 0.10 
Oral Corticosteroids 0.0374 0.0733 0.027 0.007** 
Alcohol Drinks -0.0028 -0.0125 0.0061 0.038* 
 
3.5 LASSO Models Diagnosis 
To validate the predicted best model, a residual analysis was conducted. As shown in 
Figure 14 for the percentage of slow-wave sleep model, the residuals vs. fitted plot showing the 
average value of the residuals at each value of the fitted value (red line) is overall flat. There is no 
clear distribution pattern and the residuals appear to be equally variable across the entire range of 
fitted values, except for a few values in which their observation IDs are numbered. Considering 
the very large sample size, this is completely acceptable. Although in the QQ plot, both the upper 
and lower tales are a little bit off, the overall fit is great.  The accumulative residual distribution 
looks normal, too.   
Similarly, the validation of the delta power model is displayed in Figure 15. From the 
residuals vs. fitted plot, QQ plot, and accumulative residual distribution plot, there is no indication 
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of non-linearity, heteroscedasticity, or substantial deviation from normality. This suggests that this 
LASSO model fits very well. The variance inflation factor (VIF) values were also examined based 
on best fit models. VIFs for all included variables are less than 2 (data not shown), indicating there 
is no concern for multicollinearity in these two models. 
  
 
Figure 14 Residual analysis for the percentage of slow-wave sleep LASSO model 
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Figure 15 Residual analysis for Delta Power LASSO model 
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4.0 Discussion and Conclusion 
Our final manipulated dataset contains 2767 observations and 44 variables, including 2 
outcomes. To identify the relationship between predictor variables and response variables, 
different multiple regression methods can be used to fit the models, such as ordinary least squares 
and ridge regression. In order to increase the interpretability and avoid overfitting, it is necessary 
to reduce the variable dimension and select an appropriate model based on different criteria such 
as Akaike’s Information Criterion (AIC), Schwarz’s BIC, R2, and adjusted R2 38. LASSO is one of 
the most commonly used statistical learning approaches to perform shrinkage and selection via the 
L1 regularization method 33. LASSO selection and shrinkage is much easier and faster 
computationally than other automatic variable selections such as the forward, backward and 
stepwise method. The prediction accuracy is high because shrinking and removing coefficients can 
reduce variance without a substantial increase in bias. Moreover, eliminating irrelevant variables 
that are not associated with the response variable helps to increase the model interpretability. 
In this study, we fit LASSO regression models using optimal tuning parameter λ based on 
10 folds cross-validation results to estimate what variables can explain variance in delta power 
spectra and percentage of slow-wave sleep. The past month sleep hours are positively associated 
with the percentage of slow-wave sleep. This indicates that people with longer sleep time have 
more “deep sleep.” Although last month’s sleep hours are not directly related to current sleep 
quality, a positive association indicates that it is a useful predictor in the near future for people. 
The longer the sleep time, the better and higher quality of sleep they will have. Among several 
actigraphic wake-sleep variables, none of them are associated with the percentage of slow-wave 
sleep. The amplitude is also a measure for physical activity positive. In general, the actigraphic 
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measures are well correlated with PSG data, but it may not be very reliable for more specific 
measures such as sleep efficiency 11 39. The MESOR is an averaged activity of 24 hours and may 
not be a clinically meaningful measure because the MESOR value is reflected in both day and 
night activity 36. For delta power analysis, the mean sleep minutes is negatively associated with 
delta power (Table 7). Delta power is a measure of slow-wave sleep intensity and related to prior 
sleep and wakefulness 40. Prior deprivation of sleep will enhance the delta power, while too much 
sleep will cause a decrease of delta power 13.  In our study, the negative relationship may simply 
be an indicator of too much sleep. However, it is noted that delta power can be regulated by non-
sleep related effectors such as Benzodiazepine, which can inhibit EEG delta power 13.  Some 
actigraphic parameters are not included in this study, which include shape parameter alpha (the 
relative width of the activity peak compared with rest periods), beta (the slope of the curve, with 
higher values suggesting a sharper transition between rest and activity periods), and down MESOR 
(approximating the time to ‘settle down’ for the night) 25. Fitting these parameters into the models 
may provide useful information to predict sleep quality.  
Aging is usually considered a common factor associated with changes in sleep patterns 41 
42. Our results reveal that an increase in age is negatively associated with both percentage of slow-
wave sleep and delta power, which is consistent with previous findings 41 42. The obstructive apnea-
hypopnea index is negatively associated with both the percentage of slow-wave sleep and delta 
power. The more severe patients’ obstructive apnea-hypopnea is, the lower percentage of slow-
wave sleep they have, which has an in other previous studies 43.  
There is increasing evidence showing a relationship between slow-wave sleep and diabetes. 
Suppression of slow-wave sleep increases the risk of developing type II diabetes 1. In our study, 
diabetes has a positive effect on both delta power and percentage of slow-wave sleep. The 
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relationship between diabetes and sleep could be bidirectional; a similar phenomenon was 
described between exercise and sleep 44. 
An increase in BMI indicates overweight/obesity, which is associated with an increased 
risk of many diseases including diabetes and cardiovascular diseases. Our analysis showed an 
increase in BMI attributed to both the lower level of percentage of slow-wave sleep and delta 
power.  It was suggested that the link between overweight/obesity and altered sleep quality is due 
to compromised non-rapid eye movement sleep 45.   
Interestedly, the race has a negative correlation with delta power and percentage of deep 
sleep. Compared to white people, black or other ethnic groups displayed lower delta power and a 
lower percentage of slow-wave sleep, which could be related to lower or unstable socioeconomic 
status 46. Alcohol and many medications could interfere with sleep patterns and affect sleep quality 
42 47-50. Our results showed that corticosteroids can increase the deep sleep duration and delta 
power, which is not consistent with some other studies 24 49, while benzodiazepine and NSAIDS 
have the opposite effect. The effect of corticosteroids on sleep may not be due to the medication 
itself but may be related to its treatment and improvement for some underlying diseases. 
Parkinson’s disease is usually related to poor sleep quality 51, but a recent study indicated that a 
higher accumulated power of slow waves was associated with slower motor progression, 
particularly of axial motor symptoms in Parkinson’s disease. 22. In our dataset, 1% of participants 
have Parkinson’s disease. It would be interesting to know if slow waves are related to their disease 
progress and motor function in this group of Parkinson’s disease cases. Many diseases are related 
to sleep disorders including kidney disease 52, heart failure 18, and Alzheimer’s disease 53. Our 
results indicate a positive association between kidney diseases and percentage of deep sleep. 
Kidney diseases are a large group of different disorders. Different disorders and different stages 
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of kidney function could have different clinical phenotypes. Higher Blood urea nitrogen (BUN) is 
related to daytime sleepiness in chronic kidney disease54. It is not clear if the BUN level also 
attributed the change in slow-wave sleep.  
Physical activity has long been associated with better sleep. Exercise is thought to be a 
nonpharmacologic intervention for disturbed sleep 55-57. However, some studies report that this 
correlation is weak 58. Our data showed physical activity, as well as amplitude, has no significant 
association with delta power or percentage of deep sleep (Table 4, Table 7), This inconsistency 
could be associated with the time of physical activity. The significant interaction between physical 
activity and the time spent outdoors was reported 59, which showed increasing time outdoors in the 
afternoon (versus morning) predicted lower sleep efficiency.   
The incompleteness of data is a very common problem for data analysis. Removing missing 
variables will lose some important information. Multiple imputations (MI) is now widely used to 
handle missing data. Although imputed data, particularly in the dependent variable, may add some 
noise for analysis, performing assay using multiple imputations and calculating the mean is quite 
reliable (Table 6). 
Although LASSO regression is a very powerful approach to reduce the high dimensionality 
within a dataset and to identify important variables, LASSO does not evaluate whether you have 
chosen the correct form of the relationship between the independent and dependent variable(s). 
The tuning parameter, λ, is an important parameter to determine the model selection. If we choose 
λ for minimum mean squared error, in the model for the percentage of slow-wave sleep, the λmin 
selected by the model seems the best according to Figure 10. However, in the model for delta 
power, the penalty power from λmin is weak and many noise variables are included in the initial 
model (Figure 13). The best λ range is between λmin and one standard error of the λmin or λ1se 
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(between two vertical dashed lines). In our model (Figure 12), the log lambda level increase from 
-6.1 to -5.3 does not substantially change the mean squared error but significantly increases the 
penalty power. We remodeled the linear regressing using λ = exp-5.3 and the variables selection is 
much improved and many noise variables including COPD, hypertension, congestive heart failure, 
and physical activity were removed (Table 5, Table 7). The model fits well, looks simple, and is 
easy to interpret.   
In conclusion, we used the LASSO linear regression to model the correlation between the 
two outcome variables, percentage of slow-wave sleep and delta power, and 40 other predictors 
including actigraphic rest-activity rhythm variables, subjective sleep variables, chronic diseases, 
medications, and other demographic/lifestyle factors. The tuning parameters were selected based 
on 10-fold cross-validations. The model fitting is appropriate. Our study showed that longer past 
month sleep hours, good mental performance score, and corticosteroids are positively associated 
with a higher percentage of slow-wave sleep and high delta power. Age, body mass index, 
obstructive apnea-hypopnea index, benzodiazepine, race, alcohol drinks, and mean minutes scored 
as sleep are negatively associated with either percentage of slow-wave sleep, delta power or both. 
These multimodal regression models  help the researcher to identify what factors are associated 
with participants’ two important sleep parameters related to sleep quality and sleep homeostasis 
and provide important information for future sleep study and potential development of some 
treatment strategies to preserve SWS/delta power in aging. However, some actigraphic sleep 
variables such as alpha, beta, and down-Mesor are not included in this study, but they may play an 
important role to study sleep quality in the future. Possible interactions between variables could 
exist, such as between medication and some diseases, or between physical activity and actigraphic 
measures. We did not consider the interaction term in this study but could include this in future 
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analysis. LASSO performs automatic selection and shrinking, but sometimes this may not be 
optimal. If there are strong correlations among variables, LASSO may only select one as a 
parameter group, in this situation, we may consider using sparse group LASSO or elastic net 
regularization 60. Scientific background and manual checks could improve variable selection and 
make the result more meaningful and easier to interpret.  
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Appendix Supplemental Figures and Tables 
Figure S1 Histogram of Variable Distribution 
37 
Figure S2 Distribution of Rest-activity Rhythm Variables 
38 
Table S1 Pearson Correlation Coefficients 
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Table S1 Continued (Pearson Correlation Coefficients) 
 
 
 
 
 
 
 
 
 40 
Bibliography 
1. Tasali E, Leproult R, Ehrmann DA, et al. Slow-wave sleep and the risk of type 2 diabetes in 
humans. Proc Natl Acad Sci U S A 2008;105(3):1044-9. doi: 10.1073/pnas.0706446105 
[published Online First: 2008/01/04] 
2. Blagestad T, Pallesen S, Lunde LH, et al. Sleep in older chronic pain patients: a comparative 
polysomnographic study. Clin J Pain 2012;28(4):277-83. doi: 
10.1097/AJP.0b013e3182313899 [published Online First: 2012/02/15] 
3. Lallukka T, Sivertsen B, Kronholm E, et al. Association of sleep duration and sleep quality with 
the physical, social, and emotional functioning among Australian adults. Sleep Health 
2018;4(2):194-200. doi: 10.1016/j.sleh.2017.11.006 [published Online First: 2018/03/21] 
4. Liu K, Ma Q, Wang M. Comparison of Quantitative Electroencephalogram During Sleep in 
Depressed and Non-Depressed Patients with Parkinson's Disease. Med Sci Monit 
2019;25:1046-52. doi: 10.12659/MSM.913931 [published Online First: 2019/02/08] 
5. Learning l. Brainwave activity changes dramatically across the different stages of sleep. 
https://courseslumenlearningcom/wmopen-psychology/chapter/outcome-sleep-and-
dreams/  
6. Roth T. Slow wave sleep: does it matter? J Clin Sleep Med 2009;5(2 Suppl):S4-S5. 
7. Lao XQ, Liu X, Deng HB, et al. Sleep Quality, Sleep Duration, and the Risk of Coronary Heart 
Disease: A Prospective Cohort Study With 60,586 Adults. J Clin Sleep Med 
2018;14(1):109-17. doi: 10.5664/jcsm.6894 [published Online First: 2017/12/05] 
8. Hirshkowitz M, Whiton K, Albert SM, et al. National Sleep Foundation's sleep time duration 
recommendations: methodology and results summary. Sleep Health: Journal of the 
National Sleep Foundation 2015;1(1):40-43. doi: 10.1016/j.sleh.2014.12.010 
9. Buysse DJ, Reynolds CF, 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new 
instrument for psychiatric practice and research. Psychiatry Res 1989;28(2):193-213. 
[published Online First: 1989/05/01] 
10. Grandner MA, Kripke DF, Yoon I-Y, et al. Criterion validity of the Pittsburgh Sleep Quality 
Index: Investigation in a non-clinical sample. Sleep and biological rhythms 2006;4(2):129-
39. doi: 10.1111/j.1479-8425.2006.00207.x [published Online First: 2006/06/09] 
11. Blackwell T, Redline S, Ancoli-Israel S, et al. Comparison of sleep parameters from actigraphy 
and polysomnography in older women: the SOF study. Sleep 2008;31(2):283-91. doi: 
10.1093/sleep/31.2.283 
 41 
12. Walker MP. The role of slow wave sleep in memory processing. J Clin Sleep Med 2009;5(2 
Suppl):S20-6. [published Online First: 2009/12/17] 
13. Davis CJ, Clinton JM, Jewett KA, et al. Delta wave power: an independent sleep phenotype or 
epiphenomenon? J Clin Sleep Med 2011;7(5 Suppl):S16-S18. doi: 10.5664/JCSM.1346 
14. Borbely AA, Daan S, Wirz-Justice A, et al. The two-process model of sleep regulation: a 
reappraisal. J Sleep Res 2016;25(2):131-43. doi: 10.1111/jsr.12371 [published Online 
First: 2016/01/15] 
15. Amorim L, Magalhaes R, Coelho A, et al. Poor Sleep Quality Associates With Decreased 
Functional and Structural Brain Connectivity in Normative Aging: A MRI Multimodal 
Approach. Front Aging Neurosci 2018;10:375. doi: 10.3389/fnagi.2018.00375 [published 
Online First: 2018/12/14] 
16. Bu L, Wang D, Huo C, et al. Effects of poor sleep quality on brain functional connectivity 
revealed by wavelet-based coherence analysis using NIRS methods in elderly subjects. 
Neurosci Lett 2018;668:108-14. doi: 10.1016/j.neulet.2018.01.026 [published Online First: 
2018/01/22] 
17. Elder SJ, Pisoni RL, Akizawa T, et al. Sleep quality predicts quality of life and mortality risk 
in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study 
(DOPPS). Nephrol Dial Transplant 2008;23(3):998-1004. doi: 10.1093/ndt/gfm630 
[published Online First: 2007/10/04] 
18. Turoff A, Thiem U, Fox H, et al. Sleep duration and quality in heart failure patients. Sleep 
Breath 2017;21(4):919-27. doi: 10.1007/s11325-017-1501-x [published Online First: 
2017/04/09] 
19. Ma CL, Chang WP, Lin CC. Rest/activity rhythm is related to the coexistence of pain and sleep 
disturbance among advanced cancer patients with pain. Support Care Cancer 
2014;22(1):87-94. doi: 10.1007/s00520-013-1918-0 [published Online First: 2013/09/03] 
20. St-Onge MP, Mikic A, Pietrolungo CE. Effects of Diet on Sleep Quality. Adv Nutr 
2016;7(5):938-49. doi: 10.3945/an.116.012336 [published Online First: 2016/09/17] 
21. Umigai N, Takeda R, Mori A. Effect of crocetin on quality of sleep: A randomized, double-
blind, placebo-controlled, crossover study. Complement Ther Med 2018;41:47-51. doi: 
10.1016/j.ctim.2018.09.003 [published Online First: 2018/11/28] 
22. Schreiner SJ, Imbach LL, Werth E, et al. Slow-wave sleep and motor progression in Parkinson 
disease. Ann Neurol 2019;85(5):765-70. doi: 10.1002/ana.25459 [published Online First: 
2019/03/20] 
 42 
23. Minakawa EN, Wada K, Nagai Y. Sleep Disturbance as a Potential Modifiable Risk Factor for 
Alzheimer's Disease. Int J Mol Sci 2019;20(4) doi: 10.3390/ijms20040803 [published 
Online First: 2019/02/20] 
24. Daniel LC, Li Y, Kloss JD, et al. The impact of dexamethasone and prednisone on sleep in 
children with acute lymphoblastic leukemia. Supportive care in cancer 2016;24(9):3897-
906. doi: 10.1007/s00520-016-3234-y [published Online First: 2016/04/23] 
25. Smagula SF, Krafty RT, Taylor BJ, et al. Rest-activity rhythm and sleep characteristics 
associated with depression symptom severity in strained dementia caregivers. Journal of 
sleep research 2017;26(6):718-25. doi: 10.1111/jsr.12549 [published Online First: 
2017/05/10] 
26. Ancoli-Israel S, Cole R, Alessi C, et al. The role of actigraphy in the study of sleep and 
circadian rhythms. Sleep 2003;26(3):342-92. doi: 10.1093/sleep/26.3.342 [published 
Online First: 2003/05/17] 
27. Smagula SF, Ancoli-Israel S, Blackwell T, et al. Circadian rest-activity rhythms predict future 
increases in depressive symptoms among community-dwelling older men. Am J Geriatr 
Psychiatry 2015;23(5):495-505. doi: 10.1016/j.jagp.2014.06.007 [published Online First: 
2014/06/26] 
28. Noor ZM, Smith AJ, Smith SS, et al. A feasibility study: Use of actigraph to monitor and 
follow-up sleep/wake patterns in individuals attending community pharmacy with sleeping 
disorders. J Pharm Bioallied Sci 2016;8(3):173-80. doi: 10.4103/0975-7406.171739 
29. Mariani S, Tarokh L, Djonlagic I, et al. Evaluation of an automated pipeline for large-scale 
EEG spectral analysis: the National Sleep Research Resource. Sleep Med 2018;47:126-36. 
doi: 10.1016/j.sleep.2017.11.1128 [published Online First: 2018/05/29] 
30. Marler MR, Gehrman P, Martin JL, et al. The sigmoidally transformed cosine curve: a 
mathematical model for circadian rhythms with symmetric non-sinusoidal shapes. Stat 
Med 2006;25(22):3893-904. doi: 10.1002/sim.2466 [published Online First: 2005/12/29] 
31. Krafty RT, Fu H, Graves JL, et al. Measuring Variability in Rest-Activity Rhythms from 
Actigraphy with Application to Characterizing Symptoms of Depression. Statistics in 
Biosciences 2019 doi: 10.1007/s12561-018-09230-2 
32. Honaker J, King G, Blackwell M. Amelia II: A Program for Missing Data. 2011 2011;45(7):47. 
doi: 10.18637/jss.v045.i07 [published Online First: 2011-12-12] 
33. Tibshirani R. Regression Shrinkage and Selection via the Lasso. Journal of the Royal 
Statistical Society Series B (Methodological) 1996;58(1):267-88. 
34. Choirat C HJ, Imai K, King G, Lau O Zelig: Everyone's Statistical Software, Version 5.16.1. 
http://zeligprojectorg/ 2018 
 43 
35. Friedman JH, Hastie T, Tibshirani R. Regularization Paths for Generalized Linear Models via 
Coordinate Descent. 2010 2010;33(1):22. doi: 10.18637/jss.v033.i01 [published Online 
First: 2010-02-02] 
36. Neikrug AB, Donaldson G, Iacob E, et al. Activity rhythms and clinical correlates in 
fibromyalgia. Pain 2017;158(8):1417-29. doi: 10.1097/j.pain.0000000000000906 
[published Online First: 2017/03/23] 
37. von Hippel PT. Regression with Missing Ys: An Improved Strategy for Analyzing Multiply 
Imputed Data. Sociol Methodol 2007;37:83-117. doi: DOI 10.1111/j.1467-
9531.2007.00180.x 
38. Kuk D, Varadhan R. Model selection in competing risks regression. Stat Med 
2013;32(18):3077-88. doi: 10.1002/sim.5762 [published Online First: 2013/02/26] 
39. Reid K, Dawson D. Correlation between wrist activity monitor and electrophysiological 
measures of sleep in a simulated shiftwork environment for younger and older subjects. 
Sleep 1999;22(3):378-85. doi: 10.1093/sleep/22.3.378 [published Online First: 
1999/05/26] 
40. Franken P, Chollet D, Tafti M. The homeostatic regulation of sleep need is under genetic 
control. J Neurosci 2001;21(8):2610-21. [published Online First: 2001/04/18] 
41. Landolt HP, Borbely AA. Age-dependent changes in sleep EEG topography. Clin 
Neurophysiol 2001;112(2):369-77. [published Online First: 2001/02/13] 
42. Van Cauter E, Leproult R, Plat L. Age-related changes in slow wave sleep and REM sleep and 
relationship with growth hormone and cortisol levels in healthy men. JAMA 
2000;284(7):861-8. doi: 10.1001/jama.284.7.861 [published Online First: 2000/08/11] 
43. Chervin RD, Burns JW, Ruzicka DL. Electroencephalographic Changes during Respiratory 
Cycles Predict Sleepiness in Sleep Apnea. American Journal of Respiratory and Critical 
Care Medicine 2005;171(6):652-58. doi: 10.1164/rccm.200408-1056OC 
44. Kline CE. The bidirectional relationship between exercise and sleep: Implications for exercise 
adherence and sleep improvement. Am J Lifestyle Med 2014;8(6):375-79. doi: 
10.1177/1559827614544437 
45. Pacheco SR, Miranda AM, Coelho R, et al. Overweight in youth and sleep quality: is there a 
link? Arch Endocrinol Metab 2017;61(4):367-73. doi: 10.1590/2359-3997000000265 
[published Online First: 2017/06/29] 
46. Mezick EJ, Matthews KA, Hall M, et al. Influence of race and socioeconomic status on sleep: 
Pittsburgh SleepSCORE project. Psychosom Med 2008;70(4):410-16. doi: 
10.1097/PSY.0b013e31816fdf21 
 44 
47. Thakkar MM, Sharma R, Sahota P. Alcohol disrupts sleep homeostasis. Alcohol 
2015;49(4):299-310. doi: 10.1016/j.alcohol.2014.07.019 [published Online First: 
2014/12/17] 
48. Bourgeois J, Elseviers MM, Van Bortel L, et al. One-year evolution of sleep quality in older 
users of benzodiazepines: a longitudinal cohort study in belgian nursing home residents. 
Drugs Aging 2014;31(9):677-82. doi: 10.1007/s40266-014-0203-3 [published Online 
First: 2014/08/26] 
49. Moser NJ, Phillips BA, Guthrie G, et al. Effects of Dexamethasone on Sleep. Pharmacology 
& Toxicology 1996;79(2):100-02. doi: 10.1111/j.1600-0773.1996.tb00249.x 
50. Grabovac I, Haider S, Berner C, et al. Sleep Quality in Patients with Rheumatoid Arthritis and 
Associations with Pain, Disability, Disease Duration, and Activity. J Clin Med 2018;7(10) 
doi: 10.3390/jcm7100336 [published Online First: 2018/10/12] 
51. Junho BT, Kummer A, Cardoso FE, et al. Sleep quality is associated with the severity of 
clinical symptoms in Parkinson's disease. Acta Neurol Belg 2018;118(1):85-91. doi: 
10.1007/s13760-017-0868-6 [published Online First: 2017/12/07] 
52. Nigam G, Camacho M, Chang ET, et al. Exploring sleep disorders in patients with chronic 
kidney disease. Nat Sci Sleep 2018;10:35-43. doi: 10.2147/NSS.S125839 
53. Kent BA, Michalik M, Marchant EG, et al. Delayed daily activity and reduced NREM slow-
wave power in the APPswe/PS1dE9 mouse model of Alzheimer's disease. Neurobiol Aging 
2019;78:74-86. doi: 10.1016/j.neurobiolaging.2019.01.010 [published Online First: 
2019/03/19] 
54. Pierratos A, Hanly PJ. Sleep disorders over the full range of chronic kidney disease. Blood 
Purif 2011;31(1-3):146-50. doi: 10.1159/000321859 [published Online First: 2011/01/14] 
55. Hedlund ER, Villard L, Lundell B, et al. Physical exercise may improve sleep quality in 
children and adolescents with Fontan circulation. Cardiol Young 2019:1-8. doi: 
10.1017/S1047951119001136 [published Online First: 2019/06/21] 
56. Paparrigopoulos T, Tzavara C, Theleritis C, et al. Physical activity may promote sleep in 
cardiac patients suffering from insomnia. Int J Cardiol 2010;143(2):209-11. doi: 
10.1016/j.ijcard.2008.11.178 [published Online First: 2008/12/26] 
57. Lang C, Brand S, Feldmeth AK, et al. Increased self-reported and objectively assessed physical 
activity predict sleep quality among adolescents. Physiol Behav 2013;120:46-53. doi: 
10.1016/j.physbeh.2013.07.001 [published Online First: 2013/07/16] 
58. Dolezal BA, Neufeld EV, Boland DM, et al. Interrelationship between Sleep and Exercise: A 
Systematic Review. Adv Prev Med 2017;2017:1364387-87. doi: 10.1155/2017/1364387 
[published Online First: 2017/03/26] 
 45 
59. Murray K, Godbole S, Natarajan L, et al. The relations between sleep, time of physical activity, 
and time outdoors among adult women. PloS one 2017;12(9):e0182013-e13. doi: 
10.1371/journal.pone.0182013 
60. Zou H, Hastie T. Regularization and variable selection via the elastic net. Journal of the Royal 
Statistical Society: Series B (Statistical Methodology) 2005;67(2):301-20. doi: 
10.1111/j.1467-9868.2005.00503.x 
 
